Bio-Techne Corporation (TECH)
After hours: 04:05PM EDT
| Previous close | 510.83 |
| Open | 513.33 |
| Bid | 518.30 x 1100 |
| Ask | 520.28 x 800 |
| Day's range | 508.48 - 520.52 |
| 52-week range | 250.24 - 543.85 |
| Volume | 168,800 |
| Avg. volume | 330,332 |
| Market cap | 20.356B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 149.50 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.28 (0.25%) |
| Ex-dividend date | 13 Aug 2021 |
| 1y target est | N/A |
- GlobeNewswire
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021
NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today reported financial results for the quarter and nine months ended March 31, 2021. Recent Highlights Partnership announced with University of Utah health system to improve kidney health and reduce the risk of kidney failure for large-scale populations in the earliest stages of kidney disease. KidneyIntelX to be integrated with the university electronic health records (EHR) s
- Business Wire
908 Devices and Bio-Techne Announce Joint Collaboration
908 Devices (NASDAQ: MASS) and Bio-Techne Corporation (NASDAQ: TECH) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple branded protein analysis portfolio of products, will pair its Maurice icIEF separation instrument with 908 Devices’ ZipChip device to deliver a seamless workflow for deeper protein characterization. Maurice and the iCE technology are the gold standard in protein characterization, providing absorbance and native fluorescence icIEF detection as well as CE-SDS, saving significant development time and reducing the time to commercialization.
